Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.

Sakagami T, Uchida K, Suzuki T, Carey BC, Wood RE, Wert SE, Whitsett JA, Trapnell BC, Luisetti M.

N Engl J Med. 2009 Dec 31;361(27):2679-81. doi: 10.1056/NEJMc0904077. No abstract available.

2.

Plasmapheresis for treatment of pulmonary alveolar proteinosis.

Luisetti M, Rodi G, Perotti C, Campo I, Mariani F, Pozzi E, Trapnell BC.

Eur Respir J. 2009 May;33(5):1220-2. doi: 10.1183/09031936.00097508.

3.

Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.

Uchida K, Nakata K, Suzuki T, Luisetti M, Watanabe M, Koch DE, Stevens CA, Beck DC, Denson LA, Carey BC, Keicho N, Krischer JP, Yamada Y, Trapnell BC.

Blood. 2009 Mar 12;113(11):2547-56. doi: 10.1182/blood-2009-05-155689.

4.

Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA.

Suzuki T, Sakagami T, Rubin BK, Nogee LM, Wood RE, Zimmerman SL, Smolarek T, Dishop MK, Wert SE, Whitsett JA, Grabowski G, Carey BC, Stevens C, van der Loo JC, Trapnell BC.

J Exp Med. 2008 Nov 24;205(12):2703-10. doi: 10.1084/jem.20080990. Epub 2008 Oct 27.

5.

Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1.

Martinez-Moczygemba M, Doan ML, Elidemir O, Fan LL, Cheung SW, Lei JT, Moore JP, Tavana G, Lewis LR, Zhu Y, Muzny DM, Gibbs RA, Huston DP.

J Exp Med. 2008 Nov 24;205(12):2711-6. doi: 10.1084/jem.20080759. Epub 2008 Oct 27.

6.

Rituximab and intravenous immune globulin for desensitization during renal transplantation.

Vo AA, Lukovsky M, Toyoda M, Wang J, Reinsmoen NL, Lai CH, Peng A, Villicana R, Jordan SC.

N Engl J Med. 2008 Jul 17;359(3):242-51. doi: 10.1056/NEJMoa0707894.

7.

Colony-stimulating factors in inflammation and autoimmunity.

Hamilton JA.

Nat Rev Immunol. 2008 Jul;8(7):533-44. doi: 10.1038/nri2356. Review.

PMID:
18551128
8.

Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.

Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N, Kasahara Y, Tatsumi K, Hojo M, Ichiwata T, Tanaka N, Yamaguchi E, Eda R, Oishi K, Tsuchihashi Y, Kaneko C, Nukiwa T, Sakatani M, Krischer JP, Nakata K; Japanese Center of the Rare Lung Diseases Consortium..

Am J Respir Crit Care Med. 2008 Apr 1;177(7):752-62. doi: 10.1164/rccm.200708-1271OC. Epub 2008 Jan 17.

9.

GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis.

Uchida K, Beck DC, Yamamoto T, Berclaz PY, Abe S, Staudt MK, Carey BC, Filippi MD, Wert SE, Denson LA, Puchalski JT, Hauck DM, Trapnell BC.

N Engl J Med. 2007 Feb 8;356(6):567-79.

10.

GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS.

Berclaz PY, Carey B, Fillipi MD, Wernke-Dollries K, Geraci N, Cush S, Richardson T, Kitzmiller J, O'connor M, Hermoyian C, Korfhagen T, Whitsett JA, Trapnell BC.

Am J Respir Cell Mol Biol. 2007 Jan;36(1):114-21. Epub 2006 Aug 17.

11.

Pulmonary alveolar proteinosis.

Presneill JJ, Nakata K, Inoue Y, Seymour JF.

Clin Chest Med. 2004 Sep;25(3):593-613, viii. Review.

PMID:
15331195
12.

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T.

N Engl J Med. 2004 Jun 17;350(25):2572-81.

13.

Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.

King C, Ilic A, Koelsch K, Sarvetnick N.

Cell. 2004 Apr 16;117(2):265-77.

14.

Pulmonary alveolar proteinosis.

Trapnell BC, Whitsett JA, Nakata K.

N Engl J Med. 2003 Dec 25;349(26):2527-39. Review. No abstract available.

PMID:
14695413
15.

Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4.

Bozinovski S, Jones J, Beavitt SJ, Cook AD, Hamilton JA, Anderson GP.

Am J Physiol Lung Cell Mol Physiol. 2004 Apr;286(4):L877-85. Epub 2003 Nov 14.

16.

High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.

Uchida K, Nakata K, Trapnell BC, Terakawa T, Hamano E, Mikami A, Matsushita I, Seymour JF, Oh-Eda M, Ishige I, Eishi Y, Kitamura T, Yamada Y, Hanaoka K, Keicho N.

Blood. 2004 Feb 1;103(3):1089-98. Epub 2003 Sep 25.

17.

Pulmonary alveolar proteinosis.

ROSEN SH, CASTLEMAN B, LIEBOW AA.

N Engl J Med. 1958 Jun 5;258(23):1123-42. No abstract available.

PMID:
13552931
18.

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.

Cambridge G, Leandro MJ, Edwards JC, Ehrenstein MR, Salden M, Bodman-Smith M, Webster AD.

Arthritis Rheum. 2003 Aug;48(8):2146-54.

19.

PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor.

Bonfield TL, Raychaudhuri B, Malur A, Abraham S, Trapnell BC, Kavuru MS, Thomassen MJ.

Am J Physiol Lung Cell Mol Physiol. 2003 Nov;285(5):L1132-6. Epub 2003 Aug 1.

20.

Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.

Bonfield TL, Farver CF, Barna BP, Malur A, Abraham S, Raychaudhuri B, Kavuru MS, Thomassen MJ.

Am J Respir Cell Mol Biol. 2003 Dec;29(6):677-82. Epub 2003 Jun 12.

PMID:
12805087

Supplemental Content

Support Center